Ausgabe 1-2/2001
Inhalt (19 Artikel)
Molecular and Physiologic Mechanisms of Drug Resistance in Cancer: An Overview
R.S. Kerbel
Drug Resistance in Melanoma: Mechanisms, Apoptosis, and New Potential Therapeutic Targets
Douglas Grossman, Dario C. Altieri
Multidrug Resistance in Brain Tumors: Roles of the Blood–brain Barrier
Anthony Régina, Michel Demeule, Alain Laplante, Julie Jodoin, Claude Dagenais, France Berthelet, Albert Moghrabi, Richard Béliveau
Lineage-specific Mechanism of Drug and Radiation Resistance in Melanoma Mediated by Tyrosinase-related Protein 2
Brian J. Pak, Wendy Chu, Shi Jiang Lu, Robert S. Kerbel, Yaacov Ben-David
Translational Regulation as a Novel Mechanism for the Development of Cellular Drug Resistance
John C. Schmitz, Jun Liu, Xiukun Lin, Tian-min Chen, Wu Yan, Ningwen Tai, Ashwin Gollerkeri, Edward Chu
Mechanisms Associated with cell Adhesion Mediated Drug Resistance (CAM-DR) in Hematopoietic Malignancies
Lori A. Hazlehurst, William S. Dalton
Death Receptor Ligands, in Particular TRAIL, to Overcome Drug Resistance
S. de Jong, T. Timmer, F.J. Heijenbrok, E.G.E. de Vries
Possible Mechanisms of Acquired Resistance to Anti-angiogenic Drugs: Implications for the Use of Combination Therapy Approaches
Robert S. Kerbel, Joanne Yu, Jennifer Tran, Shan Man, Alicia Viloria-Petit, Giannoula Klement, Brenda L. Coomber, Janusz Rak
The Role for Liposomal Drug Delivery in Molecular and Pharmacological Strategies to Overcome Multidrug Resistance
Lawrence D. Mayer, Jennifer A. Shabbits
Prospects for Targeting Protein Kinase C Isozymes in the Therapy of Drug-resistant Cancer – An Evolving Story
Catherine A. O'Brian, Nancy E. Ward, Jubilee R. Stewart, Feng Chu
Adjuvant Treatment of Colorectal Cancer: Towards Tumor-specific Immunotherapies
AJM van den Eertwegh, A Baars, HM Pinedo
Targeting Molecular Signals in Chk1 Pathways as a New Approach for Overcoming Drug Resistance
Gunnar Hapke, Ming-biao Yin, Youcef M. Rustum